The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both <it>in vitro </it>and <it>in vivo</it>
<p>Abstract</p> <p>Background</p> <p>Perifosine is a membrane-targeted alkylphospholipid developed to inhibit the PI3K/Akt pathway and has been suggested as a favorable candidate for combined use with radiotherapy. In this study, we investigated the effect of the combined treatment of perifosine and...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2011-04-01
|
| Serie: | Radiation Oncology |
| Accesso online: | http://www.ro-journal.com/content/6/1/39 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|